Acromegaly Cases in the US Could Increase by 11.8% Over the Next Decade: GlobalData

Diagnosed prevalent cases of acromegaly in the 7 major markets (7MM*) combined is projected to grow from 43,220 cases in 2019 to 47,340 in 2029, at an annual growth rate (AGR) of 0.95 percent, reports GlobalData, a leading data and analytics company.

GlobalData's latest article, �Acromegaly and Gigantism - Epidemiology Forecast to 2029', remarks that the principal drivers for the increasing trend in the diagnosed prevalent cases of acromegaly could be attributable to better awareness of the disease, as well as increased diagnostic techniques and changing population demographics in the respective markets.

‘Acromegaly progression can result in significant health problems such as diabetes mellitus, hypertension, cardiovascular disease, sleep apnea, carpal tunnel syndrome, and spinal cord compression.’

Suneedh Manthri, Associate Project Manager of Epidemiology at GlobalData, states: "The majority of the diagnosed prevalent cases of acromegaly in the 7MM are assumed to occur in men and women ages 40-69 years, which, in this study, is driven by a higher proportion of the population being in this age group. Acromegaly is more prevalent in women, who present at an older age with longer diagnostic delay. At presentation, women have a greater growth hormone level compared to men. Among acromegaly patients, the quality of life is more negatively affected by women both before and after treatment."

Among the 7MM, the United States is expected to have the highest number of diagnosed prevalent cases of acromegaly with 26,549 cases in 2019 and growing at an AGR of 1.18 percent (2019-2029), followed by Italy (4,005 cases) and Germany (3,354 cases).

Source: Medindia